Global Targeted DNA & RNA Sequencing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Targeted DNA & RNA Sequencing Market Research Report 2024
According to MRAResearch’s new survey, global Targeted DNA & RNA Sequencing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Targeted DNA & RNA Sequencing market research.
Key companies engaged in the Targeted DNA & RNA Sequencing industry include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN and BGI, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Targeted DNA & RNA Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Targeted DNA & RNA Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Targeted DNA & RNA Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.
Segment by Type
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Targeted DNA & RNA Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Key companies engaged in the Targeted DNA & RNA Sequencing industry include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN and BGI, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Targeted DNA & RNA Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Targeted DNA & RNA Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Targeted DNA & RNA Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.
Segment by Type
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Segment by Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Targeted DNA & RNA Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source